Product Portfolio
Urology / Gynecology
Cystozak®
Proprietary advantage:
Patented formula
Recommendations for use:
A non-antimicrobial approach to recurrent urinary tract infectionsClinical Study References:
1. Ribić, R., Meštrović, T., Neuberg, M., & Kozina, G. (2018). Effective anti-adhesives of uropathogenic Escherichia coli. Acta Pharmaceutica, 68(1), 1–18. doi:10.2478/acph-2018-0004. 2. R. V. Geetha et al: Nature’s Weapons Against Urinary Tract Infections. Int. J. Drug Dev. & Res., July-Sep 2011, 3 (3): 85-100. 3. Balakrishnan I, Hill V. Dealing with urinary tract infections. The Pharmaceutical Journal, 2011; Vol. 287, P. 687-690. 4. Jaipakdee S et al. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients. J Med Assoc Thai. 2004 Mar;87(3):255-63.
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Formulation: Powder
Packaging: Sachet
Target Population: Adults